Author: Paul Fletcher - Page 2

Dizziness and Lightheadedness as Medication Side Effects: What You Need to Know

Posted by Paul Fletcher
9 Comments

Dizziness and Lightheadedness as Medication Side Effects: What You Need to Know

Dizziness and lightheadedness are common side effects of many medications, affecting 1 in 5 adults. Learn which drugs cause it, why it happens, and how to manage it safely without stopping treatment.

read more
How Generic Drugs Are Made: The Full Manufacturing Process Explained

Posted by Paul Fletcher
10 Comments

How Generic Drugs Are Made: The Full Manufacturing Process Explained

Generic drugs are just as safe and effective as brand-name medications but cost up to 85% less. Learn how they’re made, tested, and approved by the FDA through the ANDA process-step by step.

read more
Menopause Weight Gain: How Hormones, Muscle Loss, and Strategy Shape Your Body After 45

Posted by Paul Fletcher
13 Comments

Menopause Weight Gain: How Hormones, Muscle Loss, and Strategy Shape Your Body After 45

Menopause weight gain isn't about overeating-it's hormonal shifts, muscle loss, and a slower metabolism. Learn the science-backed strategies to fight belly fat and protect your long-term health.

read more
International Counterfeit Drugs: The Hidden Dangers of Ordering Medication from Abroad

Posted by Paul Fletcher
14 Comments

International Counterfeit Drugs: The Hidden Dangers of Ordering Medication from Abroad

Ordering medication from foreign websites may save money, but it puts your life at risk. Counterfeit drugs are widespread, often deadly, and nearly impossible to detect. Learn how to avoid them and stay safe.

read more
International Regulatory Approaches to NTI Generics: What Every Prescriber Needs to Know

Posted by Paul Fletcher
8 Comments

International Regulatory Approaches to NTI Generics: What Every Prescriber Needs to Know

NTI generics require stricter regulation than standard generics due to narrow margins between effective and toxic doses. This article explores how the FDA, EMA, Canada, and Japan differ in their approaches, what’s changing in 2025, and why prescribers must stay cautious.

read more
Supportive Care in Cancer: How Growth Factors, Antiemetics, and Pain Relief Improve Outcomes

Posted by Paul Fletcher
11 Comments

Supportive Care in Cancer: How Growth Factors, Antiemetics, and Pain Relief Improve Outcomes

Supportive care in cancer uses growth factors, antiemetics, and pain relief to manage treatment side effects, improve survival, and keep patients on track. Learn how these evidence-based tools work and why access remains unequal.

read more
Government Response to Drug Shortages: Federal Actions and Policy Shifts in 2025

Posted by Paul Fletcher
8 Comments

Government Response to Drug Shortages: Federal Actions and Policy Shifts in 2025

In 2025, the U.S. government expanded its drug shortage response with a new API stockpile program, but gaps in enforcement, funding, and economic incentives leave hospitals and patients vulnerable to ongoing shortages of critical medications.

read more
Tentative Approval for Generics: Common Reasons for Delays

Posted by Paul Fletcher
12 Comments

Tentative Approval for Generics: Common Reasons for Delays

Tentative FDA approval for generics means the drug is scientifically ready - but legal, manufacturing, or economic barriers often block its market launch. Here's why so many generics never reach patients.

read more
Drug Safety Monitoring: How the FDA Tracks Generic Drugs After Approval

Posted by Paul Fletcher
9 Comments

Drug Safety Monitoring: How the FDA Tracks Generic Drugs After Approval

The FDA doesn't stop monitoring generic drugs after approval. Using real-time data, inspections, and patient reports, it tracks safety issues long after these affordable medications hit the market. Here's how it works.

read more
Immunotherapy: How Checkpoint Inhibitors and CAR-T Cell Therapy Are Changing Cancer Treatment

Posted by Paul Fletcher
16 Comments

Immunotherapy: How Checkpoint Inhibitors and CAR-T Cell Therapy Are Changing Cancer Treatment

Checkpoint inhibitors and CAR-T cell therapy are transforming cancer treatment by harnessing the immune system. Learn how they work, who benefits most, their side effects, and why access remains unequal.

read more